Birch E E, Swanson W H, Stager D R, Woody M, Everett M
Retina Foundation of the Southwest, Dallas, TX 75231.
Invest Ophthalmol Vis Sci. 1993 Dec;34(13):3687-99.
To evaluate whether very early treatment for congenital unilateral cataract results in better long-term functional outcomes, grating acuity, contrast sensitivity, recognition acuity, and random-dot stereoacuity were evaluated in two groups of children.
Grating acuity and contrast sensitivity data were obtained with standard forced-choice protocols. Stereoacuity data were obtained both in a forced-choice laboratory protocol and by the Randot test.
Immediately after treatment, both the very early (1 to 6 weeks; n = 8) and early (2 to 8 months; n = 6) treatment groups showed a 0.3 log unit grating acuity deficit in the aphakic eye. Grating acuity in the early group showed some improvement with age but reached a plateau of 0.75 logMAR at 18 to 24 months; the very early group showed more improvement and reached a plateau of 0.22 logMAR at 37 to 48 months. At 5 to 8 years of age, aphakic eyes of the very early group had significantly better contrast sensitivity and recognition acuity than the aphakic eyes of the early group. Overall, grating acuity deficits during years 2 through 5 were significantly correlated with contrast sensitivity and recognition acuity outcomes measured at 5 to 8 years of age. No deficits in grating acuity, contrast sensitivity, or recognition acuity were found for phakic fellow eyes in either group. Three children in the very early treatment group (37.5%) were orthotropic and demonstrated gross random-dot stereopsis; one child in the early group was orthotropic but none of these children demonstrated random-dot stereopsis.
These results suggest that treatment initiated at 1 to 6 weeks of age maximizes the opportunity for normal or near-normal visual development of a congenitally cataractous eye with little or no risk to the phakic fellow eye.
为评估先天性单侧白内障的极早期治疗是否能带来更好的长期功能预后,对两组儿童的光栅视力、对比敏感度、识别视力和随机点立体视锐度进行了评估。
采用标准的强制选择方案获取光栅视力和对比敏感度数据。通过强制选择实验室方案和兰多测试获取立体视锐度数据。
治疗后即刻,极早期(1至6周;n = 8)和早期(2至8个月;n = 6)治疗组的无晶状体眼均表现出0.3对数单位的光栅视力缺陷。早期治疗组的光栅视力随年龄有所改善,但在18至24个月时达到0.75 logMAR的平台期;极早期治疗组改善更为明显,在37至48个月时达到0.22 logMAR的平台期。在5至8岁时,极早期治疗组的无晶状体眼的对比敏感度和识别视力明显优于早期治疗组的无晶状体眼。总体而言,第2至5年的光栅视力缺陷与5至8岁时测量的对比敏感度和识别视力结果显著相关。两组中有晶状体的对侧眼在光栅视力、对比敏感度或识别视力方面均未发现缺陷。极早期治疗组中有3名儿童(37.5%)为正视眼并表现出粗略的随机点立体视;早期治疗组中有1名儿童为正视眼,但这些儿童均未表现出随机点立体视。
这些结果表明,在1至6周龄开始治疗可最大限度地提高先天性白内障眼正常或接近正常视觉发育的机会,对有晶状体的对侧眼几乎没有风险。